SH22-011 - WA STATE HCA MOUD IN JAILS PSA - Amendment 1 - partially executed

Home Browse Search

place of opioid agonist or partial agonist if the individual so chooses, but they may not be the only withdrawal treatment available. f. Methadone and buprenorphine must be administered daily or more frequently. Alternate -day ("Balloon") dosing of buprenorphine may be used in rare cases based on a clinical need, the decision for which is arrived at jointly between the healthcare provider and patient and is well- documented in the patient's medical record. g. Release planning and reentry coordination completed as soon as possible to ensure an effective plan is in place prior to release or in the event of an unexpected release of an incarcerated individual who needs continued treatment and services. h. Provide at least 2 doses of naloxone and naloxone administration training to all incarcerated individuals with OUD upon release. i. Schedule the first community appointment with a treatment facility. j. Provide — in hand upon release and at no cost to the individual — sufficient doses of MOUD to bridge patient until scheduled MOUD follow-up appointment at community treatment facility (does not apply to patients treated with injectable MOUD). i. Individuals who are at risk of being released directly from court are informed, prior to going to court, that they may request to be transported back to the jail by staff to receive these medications prior to going home. ii. In situations where an appointment cannot be made, e.g., after-hours bail-out, resident is given enough medication to last until the next available appointment at the community treatment facility. If that date is unknown, the individual is given a minimum of a 7 -day supply. iii. In situations where medications cannot be provided upon release, e.g., unscheduled release at a time when medical staff are not present in the jail, the individual is informed that he/she may either return to the jail in the morning to receive bridge medications or, if no medical staff are present the following day, will have a prescription for the same bridging medication called to a local pharmacy, at no cost to the individual. k. Ensure policies and procedures are in place to mitigate medication diversion. 3. Scope of Work Activities. a. Kittitas County Jail will achieve the core components of the MOUD program through the following activities: i. Purchase of MOUD: buprenorphine (Suboxone) and Sublocade. Purchasing and storage of all MOUD must follow the laws and rules pertaining to locked storage of controlled substances and any pharmacy or prescription laws that pertain. ii. An MOUD clerical position will be hired with expertise in the health care system to support the program reporting and data collection requirements and assist the program manager. This position will also develop the operation of the new electronic medical file system. iii. Hire MOUD nurse for three days per week for jail to provide 7 day per week coverage. iv. Technology improvements: an electronic medical file system, startup, monthly subscription, and server. This system will replace various systems including the outdated and inefficient use of paper files for medical records. This system will allow for Kittitas County Jail to collect and share data for reporting requirements. v. Tablets and cases for telehealth services, video conferencing and workstation technology and supplies for staff specific to this program. Three medication carts will also be purchased for each facility area. vi. Work collaboratively with the University of Washington Addictions, Drug and Alcohol Institute (ADAI) technical assistance staff to identify training needs and participate in peer- to-peer and educational learning opportunities. b. Kittitas County Jail is enhancing the current MOUD program with this funding. The improvements made will allow for staff to be more effective in improving the standard of care and implementation of the core components of this contract. Washington State Health Care Authority Page 4 HCA Contract No. K5885-1